Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

IGG's lead compound enters the clinic

April 1, 1997

New antitumor agents from Daiichi

April 1, 1997

Evanston Hospital discloses radio- and chemosensitizers

March 27, 1997

Aphton issued U.S. patents covering Gastrimmune

March 26, 1997

Kitasato Institute discovers inhibitor of IL-6 activity

March 26, 1997

Taiho discloses antiangiogenic agents

March 26, 1997

Geron and Pharmacia & Upjohn collaborate on telomerase inhibitors

March 25, 1997

Sparta's i.v. formulation of busulfan enters phase I

March 25, 1997

Tokyo University researchers characterize new steroidal saponin

March 25, 1997

Daiichi discloses new antitumor agents

March 25, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...